Nutex Health Files Additional Proxy Materials
Ticker: NUTX · Form: DEFA14A · Filed: Jun 3, 2025 · CIK: 1479681
Sentiment: neutral
Topics: proxy-filing, sec-filing, shareholder-communication
Related Tickers: NUTX
TL;DR
NUTX filed more proxy docs, shareholders get more info for voting.
AI Summary
Nutex Health, Inc. filed a Definitive Additional Materials proxy statement on June 3, 2025. This filing relates to the company's proxy materials, indicating it's providing supplementary information to shareholders. The filing does not appear to be a preliminary proxy statement or a solicitation under Rule 14a-12.
Why It Matters
This filing provides shareholders with updated or supplementary information regarding Nutex Health's proxy matters, which is crucial for informed voting decisions.
Risk Assessment
Risk Level: low — This is a routine filing of additional proxy materials, not indicating any immediate financial or operational risk.
Key Players & Entities
- Nutex Health, Inc. (company) — Registrant
- 0001558370-25-008371 (filing_id) — Accession Number
- 20250603 (date) — Filing Date
- Clinigence Holdings, Inc. (company) — Former Company Name
- iGambit, Inc. (company) — Former Company Name
FAQ
What type of filing is this DEFA14A for Nutex Health, Inc.?
This is a Definitive Additional Materials filing, as indicated by the checked box and the filing type.
When was this filing submitted to the SEC?
The filing was submitted on June 3, 2025.
What is the company's primary business address listed in the filing?
The business address is 6030 S. RICE AVE., SUITE C, HOUSTON, TX 77081.
Has Nutex Health, Inc. operated under any previous names?
Yes, the company was formerly known as Clinigence Holdings, Inc. and iGambit, Inc.
Is this filing a preliminary proxy statement?
No, this filing is marked as Definitive Additional Materials, not a Preliminary Proxy Statement.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on June 3, 2025 regarding Nutex Health, Inc. (NUTX).